| Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer B Dong, J Miao, Y Wang, W Luo, Z Ji, H Lai, M Zhang, X Cheng, J Wang, ... Communications biology 3 (1), 778, 2020 | 136 | 2020 |
| T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy Y Zhai, J Wang, T Lang, Y Kong, R Rong, Y Cai, W Ran, F Xiong, C Zheng, ... Nature Nanotechnology 16 (11), 1271-1280, 2021 | 114 | 2021 |
| Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation Y He, Z Ji, Y Gong, L Fan, P Xu, X Chen, J Miao, K Zhang, W Zhang, P Ma, ... Cell reports 42 (2), 2023 | 58 | 2023 |
| Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate X Wang, H Xu, C Cheng, Z Ji, H Zhao, Y Sheng, X Li, J Wang, Y Shu, ... Nature communications 11 (1), 706, 2020 | 51 | 2020 |
| Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling C Cheng, Z Ji, Y Sheng, J Wang, Y Sun, H Zhao, X Li, X Wang, Y He, ... Theranostics 8 (17), 4633, 2018 | 37 | 2018 |
| The histone methyltransferase Setd2 is indispensable for V (D) J recombination Z Ji, Y Sheng, J Miao, X Li, H Zhao, J Wang, C Cheng, X Wang, K Liu, ... Nature Communications 10 (1), 3353, 2019 | 36 | 2019 |
| Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer C Cheng, J Wang, P Xu, K Zhang, Z Xin, H Zhao, Z Ji, M Zhang, D Wang, ... Nature cancer 3 (5), 565-580, 2022 | 35 | 2022 |
| Lenvatinib-and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer C Zheng, W Zhang, J Wang, Y Zhai, F Xiong, Y Cai, X Gong, B Zhu, ... Acta Pharmaceutica Sinica B 12 (9), 3726-3738, 2022 | 22 | 2022 |
| ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers N Jing, K Zhang, X Chen, K Liu, J Wang, L Xiao, W Zhang, P Ma, P Xu, ... Journal of Clinical Investigation 133 (24), e168670, 2023 | 16 | 2023 |
| IL‐1β Is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer D Wang, C Cheng, X Chen, J Wang, K Liu, N Jing, P Xu, X Xi, Y Sun, Z Ji, ... Advanced Science 10 (17), 2206889, 2023 | 15 | 2023 |
| Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells Y Sheng, Z Ji, H Zhao, J Wang, C Cheng, W Xu, X Wang, Y He, K Liu, L Li, ... Cell Proliferation 52 (4), e12611, 2019 | 14 | 2019 |
| A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour‐immune cell communication K Liu, N Jing, D Wang, P Xu, J Wang, X Chen, C Cheng, Z Xin, Y He, ... Cell Proliferation 54 (7), e13056, 2021 | 11 | 2021 |
| Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer D Wang, G Du, X Chen, J Wang, K Liu, H Zhao, C Cheng, Y He, N Jing, ... Cell Death & Differentiation, 1-13, 2024 | 10 | 2024 |
| Zeb1 sustains hematopoietic stem cell functions by suppressing mitofusin-2-mediated mitochondrial fusion K Zhang, H Zhao, Y Sheng, X Chen, P Xu, J Wang, Z Ji, Y He, WQ Gao, ... Cell death & disease 13 (8), 735, 2022 | 8 | 2022 |
| Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer K Zhang, K Liu, B Hu, G Du, X Chen, L Xiao, Y Zhang, L Jiang, N Jing, ... Nature Communications 15 (1), 9050, 2024 | 2 | 2024 |
| Interleukin 15‐Presenting Nanovesicles with Doxorubicin‐Loaded Ferritin Cores for Cancer Immunochemotherapy Y Zhai, W Zhang, J Wang, Y Kong, R Rong, T Lang, C Zheng, Y Wang, ... Advanced Science 12 (4), 2409194, 2025 | | 2025 |
| 甲基化转移酶 SETD2 在血液系统恶性疾病中的作用 盛雅茹， 吉忠忠， 王金名， 赵惠芳， 何雨蔓， 朱鹤 肿瘤 40 (2), 137-145, 2020 | | 2020 |
